AAII – UTEP AI News Digest home
UTEP · AAIIAI News Digest
Archived digest · Week of Mar 16 - Mar 22, 2026

Applied AI news,
scored for your field

Each week the Institute for Applied AI Innovation reviews AI publications and scores them for Research Relevance, Educational Value, Innovation/Novelty, Practical Impact, Interdisciplinary Potential and Ethical/Policy Implications. Then it writes summaries for each discipline at UTEP.

Read the top 10 →
Your Discipline 2 stories

The Week at a Glance

Biological & Biomedical Sciences · Mar 16 - Mar 22, 2026

Biological & Biomedical Sciences. Molecular/cellular biology, biochemistry, epidemiology, toxicology, and biomedical discovery. Prefers translational research and lab-tech updates.
Departments: Biological Sciences, Pharmaceutical Sciences
Biological & Biomedical Sciences

AI Revolutionizes Drug Discovery and Research Automation

Recent advancements in artificial intelligence are significantly transforming the landscape of drug discovery and biomedical research. OpenAI is developing fully automated researchers that leverage large language models to enhance scientific inquiry. Meanwhile, Roche and Genentech are implementing AI-driven strategies to streamline their drug discovery processes, integrating experimental data and AI in a cohesive manner. These innovations promise to accelerate breakthroughs in diagnostics and therapeutic development.

Download the PDF Digest
Key Findings
  • OpenAI is enhancing large language models for scientific research tasks.
  • Roche's Lab-in-the-Loop strategy integrates AI with experimental data.
  • Genentech aims for nearly 90% efficiency in small-molecule drug discovery.
Implications
  • Increased automation in research could lead to faster scientific discoveries.
  • AI integration may reduce costs and time in drug development processes.
  • The collaboration between AI and biomedical sciences could redefine research methodologies.

Key Metrics

Numbers reported in that week's stories
90%Efficiency target for Genentech's small-molecule drug discovery
Weekly summary for Biological & Biomedical Sciences

Biological & Biomedical Sciences

Top articles by AAII Impact Score (out of 30).

Browse the archive ›
No. 1 · Computer Science

OpenAI is throwing everything into building a fully automated researcher

Research Computer ScienceBiological SciencesChemistry & BiochemistryPhysicsMathematical Sciences
· 03/20/2026
26/30 AAII Impact Score

AI Summary: Researchers at OpenAI are advancing the capabilities of large language models (LLMs) to tackle long-running scientific research tasks, building on the success of coding agents like Codex. The development of reasoning models has enhanced the ability of these systems to work independently for extended periods, enabling them to manage complex problems by breaking them into subtasks. Recent applications of GPT-5 have led to new solutions for unsolved mathematical problems and breakthroughs in biology, chemistry, and physics. OpenAI aims to apply the problem-solving capabilities demonstrated in coding to broader scientific challenges, prioritizing real-world relevance over theoretical achievements.

Topics: Large Language ModelsReasoning ModelsAutomated ResearchScientific Problem Solving
AI Rubric Scores
Research Relevance
5
Educational Value
4
Innovation/Novelty
5
Practical Impact
5
Interdisciplinary Potential
4
Ethical/Policy Implications
3
Read the full article ›
No. 2 · Pharmaceutical Sciences 22/30

Roche Scales NVIDIA AI Factories Globally to Accelerate Drug Discovery, Diagnostic Solutions and Manufacturing Breakthroughs

· 03/16/2026
Business Pharmaceutical SciencesBiological SciencesComputer ScienceIndustrial, Manufacturing & Systems Engineering

AI Summary: Roche and Genentech are enhancing their drug discovery processes through the integration of AI, particularly within Genentech's Lab-in-the-Loop strategy, which connects experiments, data, and AI in an iterative manner. Nearly 90% of Genentech's small-molecule programs utilize AI, resulting in significant time savings, such as a 25% reduction in the design time for a degrader molecule and a backup drug candidate developed in seven months instead of over two years. Additionally, Roche is modernizing pharmaceutical manufacturing by creating digital twins of production facilities using NVIDIA Omniverse libraries, which allows for the simulation and optimization of complex systems prior to implementation. This infrastructure aims to accelerate drug discovery and manufacturing processes, ultimately benefiting patients awaiting new treatments.

Topics: Healthcare AILab-in-the-Loop StrategyDigital Twins in ManufacturingAI-Driven Drug Discovery
AI Rubric Scores +
Research Relevance
4
Educational Value
3
Innovation/Novelty
4
Practical Impact
5
Interdisciplinary Potential
4
Ethical/Policy Implications
2
Read Full Article ›
Audio Summary

Generating...

Weekly Digest Summary

Error.

AI News Chatbot
...
$0.0000
AI

Hello! Ask me anything about this weeks digest.